EC Number | Cloned (Comment) | Organism |
---|---|---|
1.1.1.141 | expression in Escherichia coli | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.141 | 15-deoxy-DELTA12,14-prostaglandin J2 | 0.024 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | Berberine | 0.023 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | Biochanin A | 0.031 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | chalcone | 0.016 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | chrysin | 0.021 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | ciglitazone | 0.003 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | curcumin | 0.01 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | DuP 697 | 0.022 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | epigallocatechin gallate | 0.012 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | Flufenamic acid | 0.041 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | flurbiprofen | 0.062 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | indomethacin | 0.066 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | ketorolac | 0.028 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | Meclofenamic acid | 0.073 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | Mefenamic acid | 0.076 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | MK 886 | 0.037 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | N-(2-phenylethyl)-indomethacin amide | 0.098 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | N-(3-pyridyl)-indomethacin amide | 0.1 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | niflumic acid | 0.058 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | nimesulide | 0.051 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | NS 398 | 0.064 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | resveratrol | 0.054 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | rosiglitazone | 0.026 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | sulindac | 0.041 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | sulindac sulfide | 0.018 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | sulindac sulfone | 0.038 mM, 50% inhibition | Homo sapiens | |
1.1.1.141 | troglitazone | 0.34 mM, 50% inhibition | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.1.1.141 | cytosol | - |
Homo sapiens | 5829 | - |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.141 | (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate + NAD+ | Homo sapiens | - |
(5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NADH + H+ | - |
r |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.1.141 | Homo sapiens | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.1.1.141 | recombinant 15-PGDH | Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.1.1.141 | placenta | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.141 | (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate + NAD+ | - |
Homo sapiens | (5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NADH + H+ | - |
r |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.1.1.141 | NAD+-dependent 15-PGDH | - |
Homo sapiens |